Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trialBob W. van Oosten, Chris H. Polman, John McLeod et al.|Neurology|1997Cited by 268
MS Functional CompositeNynke F. Kalkers, Chris H. Polman, H. J. Adèr et al.|Neurology|2000Cited by 98
Erratum to “Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy” [J. Neurol. Sci. 184 (2001) 155–162]Nynke F. Kalkers, Frederik Barkhof, H. J. Adèr et al.|Journal of the Neurological Sciences|2001Cited by 1